Volume 4  Issue 1

Volume 4  Issue 1

_____________________________________________________________________________________________________

Original Article

Language Outcomes in Late Preterm Infants: A Population-based Birth Cohort Study

Sheri Crow, MD1,2, Chaitanya Undavalli1, Ruth Stoeckel1, Amy Weaver2, Robert Colligan3, Virginia Schuning1, Slavica Katusic1,2 and Malinda N Harris1

Early preterm birth (<34 weeks gestational age [GA]) is a well-established risk factor for neurodevelopmental deficit, ranging from cerebral palsy to learning disabilities and speech and language impairment (LI). In general prevalence of language impairment is estimated to range from 2%-19%. Past investigations have documented higher rates of LI in children with early prematurity [1-4]. Data suggests LI risk may be independent of perinatal and neonatal risk factors other than gestational age [5].The risks for neurodevelopmental deficit following late preterm birth (34 to <37 weeks GA) are not as well understood, and investigations to date have yielded mixed results [6-9].To our knowledge, only three investigations have evaluated outcomes related to language following late preterm birth. Although these investigations were based on small sample sizes with relatively short follow up duration, their findings suggest that late preterm birth is a risk factor for speech and language impairment (LI) [3,10,11].

Full textDownload PDF

_____________________________________________________________________________________________________

Research Article

Acute coronary syndrome in young adult patients with a history of Kawasaki disease

Takashi Higaki, MD 1)2), Eiichi Yamamoto, MD 3), Osamu Matsuda, MD 2), Takeshi Nakano, MD3), Kyoko Konishi, MD 3, Masaaki Ohta, MD 2), Hidemi Takata, MD 1)2), Kikuko Murao, MD 2), Toshiyuki Chisaka, MD 2), Tomozo Moritani, MD 2), Ryo Tashiro, MD 2),Toshifumi Yamauchi, MD 2),Toyohisa Miyata, MD 2),Ryusuke Watanabe, MD 2),Keisuke Urata, MD 2),Haruka Iwata, MD 2),Ryoji Niino, MD 2),Atsushi Kawamoto, MD 2),Yusuke Akazawa, MD 2),Yoshihiro Takahashi, MD 2), Eiichi Ishii, MD 1)2) , Toyofumi Yoshii, MD 4), Shinji Inaba, MD 4),Sumiko Sato, MD 4),Go matsunaka, MD 4), Jun Aono, MD 4),Hideki Okayama, MD 4), Shuntaro Ikeda, MD 4), Osamu Yamaguchi, MD 4), Shikata Fumiaki, MD 5), Ai Kojima, MD 5), Mayumi Kamata, MD 5), Mitsugi Nagashima, MD 5),Shunji Uchita, MD 5)

Twelve ACS episodes were observed in nine patients. Five out of nine patients were continuously followed up regularly with anticoagulant therapy since the onset of Kawasaki disease, the remaining four patients who did not followed. They were diagnosed with sequela of Kawasaki disease for the first time by coronary angiography when admitted to ACS.

Full textDownload PDF

_____________________________________________________________________________________________________

Editor note: Pediatrics

Kumar Blesso, M.Sc., M.Phil., PhD

Jacobs Journal of Pediatrics publishes discoveries and advancements in medical care of infants, children, and adolescents. Also, journal focuses on Pediatric Endocrinology, innate-immunity, interventional-cardiac-catheterization, pulmonary-rehabilitation, pediatric-oncology, child-obesity, inborn-errors, childhood-asthma, protein-misfolding-disorder, and pediatrics-sinusitis.

Journal of Pediatrics of volume 1 issue 2 publishes articles, verifying the relationship between mothers and their preterm infant’s cardiac autonomic modulation that can influence cardiac autonomic modulation [1], study showing that the Pediatric Advanced Life Support course is inadequate to teach pediatric residents resuscitation [2], examining inter-parental agreement on ratings of social-emotional, behavioral problems and competencies in 1 to 3 year-old children [3].

Full textDownload PDF

_____________________________________________________________________________________________________

Original Article

Henoch-Schonlein Purpura in Children: Assessment of 85 Cases

Fatih Karaaslan1, Betul Gemici Karaaslan1, Huseyin Dag1, Soner Sazak1, Emine Turkkan1, Bilal Yilmaz1, Gulsen- Kose Midillioglu2

Henoch-Schonlein purpura (HSP) was first described by Heberden in 1801 and its relationship with arthritis was highlighted by Schonlein in 1837 [1]. HSP is a leukocytoclastic vasculitis with small vessel involvement and primarily affects the skin as well as joints, the gastrointestinal system (GIS), kidneys, and more rarely, other organs. Its etiology is not entirely known [2].

Full textDownload PDF